News
UCLA and University of California officials said Monday that it will negotiate with Trump over $339 million in medical and ...
Tharimmune, Inc. (NASDAQ:THAR), ("Tharimmune" or the "Company), a clinical-stage biotechnology company dedicated to developing innovative therapeutic candidates for inflammation, immunology, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results